*Department of Ophthalmology, Eye and Ear Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania;
†Vitreous Retina Macular Consultants of New York, New York, New York;
‡LuEsther T. Merz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, New York; and
§Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania.
Reprint requests: Kunal K. Dansingani, MA, FRCOphth, UPMC Eye Center203 Lothrop Street, 8 th floor, Pittsburgh, PA 15213; e-mail: [email protected].
Supported by NIH CORE Grant P30 EY08098 to the University of Pittsburgh Department of Ophthalmology, Departmental Startup Funds to EAR from the University of Pittsburgh Department of Ophthalmology, the Eye and Ear Foundation of Pittsburgh, and from an unrestricted grant from Research to Prevent Blindness, New York, NY. The sponsor or funding organization had no role in the design or conduct of this research.
K. B. Freund is a consultant for Bayer HealthCare, Roche/Genentech, Inc., Heidelberg Engineering, Novartis, Optovue, and Carl Zeiss Meditec and receives research support from Roche/Genentech, Inc. K. K. Dansingani is a consultant for Biogen. The remaining authors have any conflicting interests to disclose.
